menu
    • menu

    Company profile for TrueBinding

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company creating new and exciting molecules for applications in neurodegenerative diseases (AD, PD, ALS), stroke, metabolic diseases, oncology and other disease areas with great unmet medical need. Based on its proprietary Truebinding™ platform, TrueBinding has to date discovered over 6 novel drug targets and developed potentially game changing monoclon...
    Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company creating new and exciting molecules for applications in neurodegenerative diseases (AD, PD, ALS), stroke, metabolic diseases, oncology and other disease areas with great unmet medical need. Based on its proprietary Truebinding™ platform, TrueBinding has to date discovered over 6 novel drug targets and developed potentially game changing monoclonal antibody drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TrueBindingUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Lincoln Centre Drive, Suite 200 Foster City, CA 94404
    Telephone
    Telephone
    650-847-1117
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.truebinding.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TrueBinding Gets FDA IND for Parkinson’s Ph 2A Trial
    TrueBinding Gets FDA IND for Parkinson’s Ph 2A Trial

    18 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/18/2983184/0/en/TrueBinding-Receives-FDA-IND-Go-Ahead-for-Parkinson-s-Phase-2A-Clinical-Trial.html

    GLOBENEWSWIRE
    18 Nov 2024
    Share Share
    TrueBinding raises more than $50M, lays off workers twice in June
    TrueBinding raises more than $50M, lays off workers twice in June

    07 Jul 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/california-alzheimers-startup-truebinding-raises-more-than-50m-lays-off-workers-twice-in-june/

    Kyle LaHucik ENDPTS
    07 Jul 2023
    Share Share
    TrueBinding Granted Type B End-of-Phase 2 Meeting with FDA for TB006
    TrueBinding Granted Type B End-of-Phase 2 Meeting with FDA for TB006

    14 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/truebinding-granted-type-b-end-of-phase-2-meeting-with-fda-for-discussion-of-accelerated-development-pathway-for-tb006-alzheimers-disease-treatment-301770786.html

    PR NEWSWIRE
    14 Mar 2023
    Share Share
    TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action
    TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action

    06 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/06/2568267/0/en/TrueBinding-Highlights-the-Potential-of-TB006-s-Unique-Mechanism-of-Action-as-a-Novel-Approach-for-the-Treatment-of-Alzheimer-s-Disease-at-the-15th-Clinical-Trials-on-Alzheimer-s-D.html

    GLOBENEWSWIRE
    06 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search